1Meri Aldila Rahmanita, 2Agung Putra, 3Deddy Hermansyah
1Postgraduate student of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
2,3Department of Biomedical Sciences, Faculty of Medicine, Universitas Islam Sultan Agung, Jl Kaligawe KM 4 Semarang 50012
DOI : https://doi.org/10.47191/ijmra/v6-i12-34Google Scholar Download Pdf
ABSTRACT:
Alopecia induced by the accumulation of reactive oxygen species (ROS) stimulates changes in the immune and neuroendocrine systems. Hair follicles have dermal papillary cells (DPCs) that bind to corticotropin-releasing factor (CRF) receptors. Research shows that transforming growth factor (TGF-β) is one of the expressions that can be an indication of the influence of CRF. The effect of CRF itself is to cause hair loss. The purpose of this study was to determine the Secretome of Hypoxia Mesenchymal Stem Cells (SH-MSCs) against IL-6 expression and TGF-β expression. This study used experimentally in vivo with the Post Test Only Control Group Design method. The subjects of this study were male rats of Wistar strain which were divided into 4 treatments consisting of 1 healthy group, 1 negative control group, 1 treatment group with SH-MSCs dose 10% in a dose of 200 mg/rat/day gel, and 1 more treatment group with SH-MSCs dose 20% in a dose of 200 mg/rat/day. On the 21st day, IL-6 expression and TGF-β expression were examined. Data were analyzed using the One-Way ANOVA Test and the Kruskall-Wallis Test to determine the effect of each group. The One-Way ANOVA test showed the results of IL-6 expression (p = 0.000) showed a significant difference (p < 0.05) and the Kruskall-Wallis test of TGF-β expression (p = 0.000) with SH-MSCs dose 200 was a significant difference (p < 0.05). The administration of 10% and 20% doses of SH-MSCs in 200 mg gel may decrease IL-6 expression. Dosed SH-MSCs 20%increased TGF-β expression in alopecia-like rats. The development of the use of SH-MSCs is expected to be an alternative to alopecia therapy that is more beneficial and safe for the body.
KEYWORDS:Secretome Hypoxia Mesenchymal Stem Cells (SH-MSCs), IL-6x, TGF-β
REFERENCES1) Salhab O, Khayat L, Alaaeddine N.Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review. J Biomed Sci. 2022 Oct 5;29(1):77.
2) Deng W, Zhang Y, Wang W, Song A, Mukama O, Huang J, et al.Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle. Stem Cell Res Ther. 2021 Dec 21;12(1):548.
3) Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, et al.Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis. J Am Acad Dermatol. 2020 Mar;82(3):675–82.
4) Simakou T, Butcher JP, Reid S, Henriquez FL. Alopecia areata: A multifactorial autoimmune condition. J Autoimun. 2019 Mar;98:74–85.
5) Thompson JM, Park MK, Qureshi AA, Cho E.Race and Alopecia Areata amongst US Women. Journal of Investigative Dermatology Symposium Proceedings. 2018 Jan;19(1):S47–50.
6) Uzuncakmak TK, Engin B, Serdaroglu S, Tuzun Y.Demographic and Clinical Features of 1,641 Patients with Alopecia Areata, Alopecia Totalis, and Alopecia Universalis: A Single-Center Retrospective Study. Skin Appendage Disord. 2021;7(1):8–12.
7) Putra A, Widyatmoko A, Ibrahim S, Amansyah F, Amansyah F, Berlian MA, et al.Case series of the first three severe COVID-19 patients treated with the secretome of hypoxia-mesenchymal stem cells in Indonesia. F1000Research. 2021;10:1–19
8) Jeon SH, Hyunju KIM, Jong Hyuk Sun. Hypoxia enhances the hair growth-promoting effects of embryonic stem cell-derived mesenchymal stem cells via NADPH oxidase 4. J Biomed Pharmacotherapy. 2023 Mar;159:114303
9) Kim JE, Oh JH, Woo YJ, Jung JH, Jeong KH, Kang H.Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models. Exp Dermatol. 2020 Mar 21;29(3):265–72.
10) Andjelkov K, Eremin II, Korac A.Different levels of EGF, VEGF, IL‐6, MCP‐1, MCP‐3, IP‐10, Eotaxin and MIP‐1α in the adipose‐derived stem cell secretome in androgenetic alopecia. Exp Dermatol. 2022 Jun 19;31(6):936–42.
11) Tanaka T, Narazaki M, Kishimoto T.IL-6 in Inflammation, Immunity, and Disease. Cold Spring Harb Perspect Biol. 2014 Oct; 6(10): a016295.
12) El-RefaiAM , Elhabak DM, KhashabaDA. More is Not Always Better in Hair Growth Factors. Epidermal Growth Factor: Hair Growth Factor Involved in Alopecia Areata Pathogenesis. Int J Trichology.2020 Jul-Aug; 12(4): 182–187.
13) Walker C, Kelly E, James T et al. Hair Growth in a Patient with Alopecia. J Skin Appendage Disord (2021) 7 (5): 408–412.
14) Aisyah R, Jatmik SW. The Tgf-Β Signaling Pathway Plays a Role in Stem Cell Self-Renewal, Differentiation, and Proliferation. Journal of Medika Science Vol 15, No.1, June 2019.
15) Young L, Jehim K, Jemin K, et al.The Effect of Conditioned Media From Human Adipocyte-Derived Mesenchymal Stem Cells on Androgenetic Alopecia After Nonablative Fractional Laser Treatment. J Dermatologic Surgery 46(12):p 1698-1704, December 2020.
16) Gentile P, Maria G, Allesandra B, et al.Platelet-Rich Plasma and Micrografts Enriched with Autologous Human Follicle Mesenchymal Stem Cells Improve Hair Re-Growth in Androgenetic Alopecia. J. Biomedicines. 2019 Jun; 7(2): 27
17) Ho Bak D, Mi J, Soon R, et al.Human umbilical cord blood mesenchymal stem cells engineered to overexpress growth factors accelerate outcomes in hair growth. Korean J Physiol Pharmacol. 2018 Sep; 22(5): 555–566
18) Chang, Pauklin. ROS and TGFβ: from pancreatic tumour growth to metastasis Journal of Experimental & Clinical Cancer Research (2021) 40:152
19) Kuntardjo N, et al.Topical gel of mesenchymal stem cells-conditioned medium under TNF-α precondition accelerates wound closure healing in full-thickness skin defect animal model. J Med Life. 2022 Feb;15(2):214-221
Volume 06 Issue 12 December 2023
There is an Open Access article, distributed under the term of the Creative Commons Attribution – Non Commercial 4.0 International (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits remixing, adapting and building upon the work for non-commercial use, provided the original work is properly cited.
Our Services and Policies
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected.
The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.
International Journal of Multidisciplinary Research and Analysis will publish 12 monthly online issues per year,IJMRA publishes articles as soon as the final copy-edited version is approved. IJMRA publishes articles and review papers of all subjects area.
Open access is a mechanism by which research outputs are distributed online, Hybrid open access journals, contain a mixture of open access articles and closed access articles.
International Journal of Multidisciplinary Research and Analysis initiate a call for research paper for Volume 07 Issue 05 (May 2024).
PUBLICATION DATES:
1) Last Date of Submission : 26 May 2024 .
2) Article published within a week.
3) Submit Article : editor@ijmra.in or Online
Why with us
1 : IJMRA only accepts original and high quality research and technical papers.
2 : Paper will publish immediately in current issue after registration.
3 : Authors can download their full papers at any time with digital certificate.
The Editors reserve the right to reject papers without sending them out for review.
Authors should prepare their manuscripts according to the instructions given in the authors' guidelines. Manuscripts which do not conform to the format and style of the Journal may be returned to the authors for revision or rejected. The Journal reserves the right to make any further formal changes and language corrections necessary in a manuscript accepted for publication so that it conforms to the formatting requirements of the Journal.